Market Research Logo

Global Novel Drug Delivery Systems Market - Analysis and Forecasts 2018-2025

Global Novel Drug Delivery Systems Market - Analysis and Forecasts 2018-2025

Novel Drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. NDDS is a system for delivery of drug other than conventional drug delivery system. NDDS is a combination of advance technique and new dosage forms which are far better than conventional dosage forms.

This report studies the Novel Drug Delivery Systems market status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top manufacturers in global and major regions, and splits the Novel Drug Delivery Systems market by product type and applications/end industries.

In the last several years, global market of Novel Drug Delivery Systems developed smoothly, with an average growth rate of 2.17%. In 2017, global revenue of Novel Drug Delivery Systems is nearly 26.5 billion USD.

The major players in global Novel Drug Delivery Systems market include
Amgen
Teva
UCB (Union Chimique Belge)
Roche
Celgene
Sanofi
Merck
Johnson & Johnson
Takeda
Gilead Sciences
Pfizer
Dr Reddy
Samyang Biopharmaceuticals
TOLMAR
Astellas
AMAG Pharmaceuticals
AstraZeneca
AbbVie
Bausch£¦Lomb
TWi Pharmaceuticals
Novartis
Aspen
Shire
Breckenridge Pharmaceuticals
Galen

Geographically, this report is segmented into several key regions, with revenue, market share and growth rate of Novel Drug Delivery Systems in these regions, from 2013 to 2025 (forecast), covering
North America
Europe
Asia-Pacific
South America
Middle East and Africa

On the basis of product, the Novel Drug Delivery Systems market is primarily split into
Liposomes
PEGylated Proteins & Polypeptides
Polymer Nanoparticle
Protein¨Cdrug Conjugates
Others

On the basis on the end users/applications, this report covers
Hospitals & Clinic
Cancer Treatment Centers
Others


1 Novel Drug Delivery Systems Market Overview
1.1 Product Overview and Scope of Novel Drug Delivery Systems
1.2 Novel Drug Delivery Systems Segment by Types (Product Category)
1.2.1 Global Novel Drug Delivery Systems Revenue by Types
1.2.2 Global Novel Drug Delivery Systems Revenue Market Share by Types in 2017
1.2.3 Liposomes
1.2.4 PEGylated Proteins & Polypeptides
1.2.5 Polymer Nanoparticle
1.2.6 Protein¨Cdrug Conjugates
1.3 Global Novel Drug Delivery Systems Segment by Applications
1.3.1 Global Novel Drug Delivery Systems Revenue Comparison by Applications
1.3.2 Hospitals & Clinic
1.3.3 Cancer Treatment Centers
1.4 Global Novel Drug Delivery Systems Market by Regions (2013-2025)
1.4.1 Global Novel Drug Delivery Systems Revenue Comparison by Regions (2013-2025)
1.4.2 North America Novel Drug Delivery Systems Status and Prospect (2013-2025)
1.4.3 Europe Novel Drug Delivery Systems Status and Prospect (2013-2025)
1.4.4 Asia-Pacific Novel Drug Delivery Systems Status and Prospect (2013-2025)
1.4.5 South America Novel Drug Delivery Systems Status and Prospect (2013-2025)
1.4.6 Middle East and Africa Novel Drug Delivery Systems Status and Prospect (2013-2025)
1.5 Global Novel Drug Delivery Systems Market Size (2013-2025)
2 Global Novel Drug Delivery Systems Market Competition by Manufacturers
2.1 Global Novel Drug Delivery Systems Revenue and Share by Manufacturers (2017-2018)
2.2 Global Novel Drug Delivery Systems Gross Margin by Manufacturers (2017-2018)
2.3 Manufacturers Novel Drug Delivery Systems Headquarters, Established Date and Product
2.4 Novel Drug Delivery Systems Market Competitive Situation and Trends
2.4.1 Novel Drug Delivery Systems Market Concentration Rate
2.4.2 Novel Drug Delivery Systems Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 Global Novel Drug Delivery Systems Revenue by Regions (2013-2018)
3.1 Global Novel Drug Delivery Systems Revenue and Market Share by Regions (2013-2018)
3.2 Global Novel Drug Delivery Systems Revenue and Gross Margin (2013-2018)
3.3 North America Novel Drug Delivery Systems Revenue (2013-2018)
3.3.1 North America Novel Drug Delivery Systems Revenue and Growth Rate (2013-2018)
3.3.2 North America Novel Drug Delivery Systems Revenue and Gross Margin (2013-2018)
3.4 Europe Novel Drug Delivery Systems Revenue (2013-2018)
3.4.1 Europe Novel Drug Delivery Systems Revenue and Growth Rate (2013-2018)
3.4.2 Europe Novel Drug Delivery Systems Revenue and Gross Margin (2013-2018)
3.5 Asia-Pacific Novel Drug Delivery Systems Revenue (2013-2018)
3.5.1 Asia-Pacific Novel Drug Delivery Systems Revenue and Growth Rate (2013-2018)
3.5.2 Asia-Pacific Novel Drug Delivery Systems Revenue and Gross Margin (2013-2018)
3.6 South America Novel Drug Delivery Systems Revenue (2013-2018)
3.6.1 South America Novel Drug Delivery Systems Revenue and Growth Rate (2013-2018)
3.6.2 South America Novel Drug Delivery Systems Revenue and Gross Margin (2013-2018)
3.7 Middle East & Africa Novel Drug Delivery Systems Revenue (2013-2018)
3.7.1 Middle East & Africa Novel Drug Delivery Systems Revenue and Growth Rate (2013-2018)
3.7.2 Middle East & Africa Novel Drug Delivery Systems Revenue and Gross Margin (2013-2018)
4 Global Novel Drug Delivery Systems Revenue (Value) by Types
4.1 Global Novel Drug Delivery Systems Revenue and Market Share by Types (2013-2018)
4.2 Global Novel Drug Delivery Systems Revenue Growth Rate by Types (2013-2018)
5 Global Novel Drug Delivery Systems Market Analysis by Applications
5.1 Global Novel Drug Delivery Systems Revenue and Market Share by Applications (2013-2018)
5.2 Global Novel Drug Delivery Systems Revenue Growth Rate by Applications (2013-2018)
6 Analysis of Novel Drug Delivery Systems Industry Key Manufacturers
6.1 Amgen
6.1.1 Company Profile
6.1.2 Product Information
6.1.3 Revenue, Cost, Gross Profit and Gross Margin
6.2 Teva
6.2.1 Company Profile
6.2.2 Product Information
6.2.3 Revenue, Cost, Gross Profit and Gross Margin
6.3 UCB (Union Chimique Belge)
6.3.1 Company Profile
6.3.2 Product Information
6.3.3 Revenue, Cost, Gross Profit and Gross Margin
6.4 Roche
6.4.1 Company Profile
6.4.2 Product Information
6.4.3 Revenue, Cost, Gross Profit and Gross Margin
6.5 Celgene
6.5.1 Company Profile
6.5.2 Product Information
6.5.3 Revenue, Cost, Gross Profit and Gross Margin
6.6 Sanofi
6.6.1 Company Profile
6.6.2 Product Information
6.6.3 Revenue, Cost, Gross Profit and Gross Margin
6.7 Merck
6.7.1 Company Profile
6.7.2 Product Information
6.7.3 Revenue, Cost, Gross Profit and Gross Margin
6.8 Johnson & Johnson
6.8.1 Company Profile
6.8.2 Product Information
6.8.3 Revenue, Cost, Gross Profit and Gross Margin
6.9 Takeda
6.9.1 Company Profile
6.9.2 Product Information
6.9.3 Revenue, Cost, Gross Profit and Gross Margin
6.10 Gilead Sciences
6.10.1 Company Profile
6.10.2 Product Information
6.10.3 Revenue, Cost, Gross Profit and Gross Margin
6.11 Pfizer
6.11.1 Company Profile
6.11.2 Product Information
6.11.3 Revenue, Cost, Gross Profit and Gross Margin
6.12 Dr Reddy
6.12.1 Company Profile
6.12.2 Product Information
6.12.3 Revenue, Cost, Gross Profit and Gross Margin
6.13 Samyang Biopharmaceuticals
6.13.1 Company Profile
6.13.2 Product Information
6.13.3 Revenue, Cost, Gross Profit and Gross Margin
6.14 TOLMAR
6.14.1 Company Profile
6.14.2 Product Information
6.14.3 Revenue, Cost, Gross Profit and Gross Margin
6.15 Astellas
6.15.1 Company Profile
6.15.2 Product Information
6.15.3 Revenue, Cost, Gross Profit and Gross Margin
6.16 AMAG Pharmaceuticals
6.16.1 Company Profile
6.16.2 Product Information
6.16.3 Revenue, Cost, Gross Profit and Gross Margin
6.17 AstraZeneca
6.17.1 Company Profile
6.17.2 Product Information
6.17.3 Revenue, Cost, Gross Profit and Gross Margin
6.18 AbbVie
6.18.1 Company Profile
6.18.2 Product Information
6.18.3 Revenue, Cost, Gross Profit and Gross Margin
6.19 Bausch£¦Lomb
6.19.1 Company Profile
6.19.2 Product Information
6.19.3 Revenue, Cost, Gross Profit and Gross Margin
6.20 TWi Pharmaceuticals
6.20.1 Company Profile
6.20.2 Product Information
6.20.3 Revenue, Cost, Gross Profit and Gross Margin
6.21 Novartis
6.21.1 Company Profile
6.21.2 Product Information
6.21.3 Revenue, Cost, Gross Profit and Gross Margin
6.22 Aspen
6.22.1 Company Profile
6.22.2 Product Information
6.22.3 Revenue, Cost, Gross Profit and Gross Margin
6.23 Shire
6.23.1 Company Profile
6.23.2 Product Information
6.23.3 Revenue, Cost, Gross Profit and Gross Margin
6.24 Breckenridge Pharmaceuticals
6.24.1 Company Profile
6.24.2 Product Information
6.24.3 Revenue, Cost, Gross Profit and Gross Margin
6.25 Galen
6.25.1 Company Profile
6.25.2 Product Information
6.25.3 Revenue, Cost, Gross Profit and Gross Margin
7 Novel Drug Delivery Systems Manufacturing Cost Analysis
7.1 Novel Drug Delivery Systems Drugs R&D Cost Analysis
7.1.1 Clinical Phase Costs
7.1.2 Capitalized Costs
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.2.1 USA Labor Cost Analysis
7.2.2.2 Europe Labor Costs Analysis
7.2.2.3 Asia Labor Costs Analysis
7.2.3 Other Costs Analysis
7.2.3.1 USA Cost of Electricity Analysis
7.2.3.2 USA Water Cost Analysis
7.2.3.3 Europe Cost of Electricity Analysis
7.2.3.4 Europe Water Cost Analysis
7.2.3.5 China Cost of Electricity Analysis
7.2.3.6 China Water Cost Analysis
7.3 Manufacturing Process Analysis of Novel Drug Delivery Systems
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Novel Drug Delivery Systems Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.2.1 Introducing pharmaceutical branding strategies
9.2.2.2 Building pharmaceutical brands
9.2.2.3 Communicating pharmaceutical brands
9.2.2.4 Alternative brand models
9.2.2.5 The future of pharmaceutical branding
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 Global Novel Drug Delivery Systems Market Forecast (2019-2025)
11.1 Global Novel Drug Delivery Systems Revenue Forecast (2019-2025)
11.2 Global Novel Drug Delivery Systems Revenue Forecast by Regions (2019-2025)
11.2.1 North America Novel Drug Delivery Systems Revenue Forecast (2019-2025)
11.2.2 Europe Novel Drug Delivery Systems Revenue Forecast (2019-2025)
11.2.3 Asia-Pacific Novel Drug Delivery Systems Revenue Forecast (2019-2025)
11.2.4 South America Novel Drug Delivery Systems Revenue Forecast (2019-2025)
11.2.5 Middle East and Africa Novel Drug Delivery Systems Revenue and Revenue Forecast (2019-2025)
11.3 Global Novel Drug Delivery Systems Revenue Forecast by Types (2019-2025)
11.4 Global Novel Drug Delivery Systems Revenue Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables and Figures
Figure Product Picture of Novel Drug Delivery Systems
Table Global Novel Drug Delivery Systems Comparison by Types
Table Global Novel Drug Delivery Systems Revenue (M USD) and Growth Rate Comparison by Types (2013-2025)
Figure Global Novel Drug Delivery Systems Revenue Market Share by Types in 2017
Figure Product Picture of Liposomes
Figure Product Picture of PEGylated Proteins & Polypeptides
Figure Product Picture of Polymer Nanoparticle
Figure Product Picture of Protein¨Cdrug Conjugates
Table Global Novel Drug Delivery Systems Revenue (M USD) and Growth Rate Comparison by Applications (2013-2025)
Figure Global Novel Drug Delivery Systems Revenue Market Share by Applications in 2017
Figure Hospitals & Clinic Examples
Figure Cancer Treatment Centers Examples
Table Global Novel Drug Delivery Systems Revenue (M USD) Comparison by Regions (2013-2025)
Figure North America Novel Drug Delivery Systems Revenue (M USD) and Growth Rate (2013-2025)
Figure Europe Novel Drug Delivery Systems Revenue (M USD) and Growth Rate (2013-2025)
Figure Asia-Pacific Novel Drug Delivery Systems Revenue (M USD) and Growth Rate (2013-2025)
Figure South America Novel Drug Delivery Systems Revenue (M USD) and Growth Rate (2013-2025)
Figure Middle East and Africa Novel Drug Delivery Systems Revenue (M USD) and Growth Rate (2013-2025)
Figure Global Novel Drug Delivery Systems Revenue (M USD) Status and Outlook (2013-2025)
Table Global Novel Drug Delivery Systems Revenue (M USD) by Manufacturers (2017-2018)
Table Global Novel Drug Delivery Systems Revenue Share by Manufacturers (2017-2018)
Figure 2017 Global Novel Drug Delivery Systems Revenue Share by Manufacturers
Figure 2018 Global Novel Drug Delivery Systems Revenue Share by Manufacturers
Table Global Market Novel Drug Delivery Systems Gross Margin of Key Manufacturers (2017-2018)
Figure Global Market Novel Drug Delivery Systems Gross Margin of Key Manufacturers in 2017
Table Manufacturers Novel Drug Delivery Systems Headquarters and Established Date
Table Manufacturers Novel Drug Delivery Systems Product list
Figure 2017 Novel Drug Delivery Systems Revenue Market Share by Manufacturers
Figure 2017 Novel Drug Delivery Systems Revenue Market Share of Top 3 Manufacturers
Figure 2017 Novel Drug Delivery Systems Revenue Market Share of Top 5 Manufacturers
Table Mergers & Acquisitions, Expansion
Table Global Novel Drug Delivery Systems Revenue (M USD) by Regions (2013-2018)
Table Global Novel Drug Delivery Systems Revenue Market Share by Regions (2013-2018)
Figure Global Novel Drug Delivery Systems Revenue Market Share by Regions (2013-2018)
Figure 2017 Global Novel Drug Delivery Systems Revenue Market Share by Regions
Figure Global Novel Drug Delivery Systems Revenue (M USD) and Growth Rate (2013-2018)
Table Global Novel Drug Delivery Systems Revenue (M USD) and Gross Margin (2013-2018)
Figure North America Novel Drug Delivery Systems Revenue (M USD) and Growth Rate (2013-2018)
Table North America Novel Drug Delivery Systems Revenue (M USD) and Gross Margin (2013-2018)
Figure Europe Novel Drug Delivery Systems Revenue (M USD) and Growth Rate (2013-2018)
Table Europe Novel Drug Delivery Systems Revenue (M USD) and Gross Margin (2013-2018)
Figure Asia-Pacific Novel Drug Delivery Systems Revenue (M USD) and Growth Rate (2013-2018)
Table Asia-Pacific Novel Drug Delivery Systems Revenue (M USD) and Gross Margin (2013-2018)
Figure South America Novel Drug Delivery Systems Revenue (M USD) and Growth Rate (2013-2018)
Table South America Novel Drug Delivery Systems Revenue (M USD) and Gross Margin (2013-2018)
Figure Middle East & Africa Novel Drug Delivery Systems Revenue (M USD) and Growth Rate (2013-2018)
Table Middle East & Africa Novel Drug Delivery Systems Revenue (M USD) and Gross Margin (2013-2018)
Table Global Novel Drug Delivery Systems Revenue (M USD) by Types (2013-2018)
Table Global Novel Drug Delivery Systems Revenue Share by Types (2013-2018)
Figure Revenue Share of Novel Drug Delivery Systems by Types (2013-2018)
Figure 2017 Revenue Market Share of Novel Drug Delivery Systems by Types
Figure Global Novel Drug Delivery Systems Revenue Growth Rate by Types (2013-2018)
Table Global Novel Drug Delivery Systems Revenue (M USD) by A

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report